drugset / Trial / NCT00889486
Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of TZP-102 on gastric emptying rate, gastroparesis symptoms and health-related quality of life in diabetic patients with gastroparesis.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TZP-102 | Protein / enzyme biologic | 10 mg | Oral |
| Subject | TZP-102 | Protein / enzyme biologic | 20 mg | Oral |
| Subject | TZP-102 | Protein / enzyme biologic | 40 mg | Oral |